Literature DB >> 19758536

Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism.

Vijendra K Singh1.   

Abstract

BACKGROUND: Autism causes incapacitating neurologic problems in children that last a lifetime. The author of this article previously hypothesized that autism may be caused by autoimmunity to the brain, possibly triggered by a viral infection. This article is a summary of laboratory findings to date plus new data in support of an autoimmune pathogenesis for autism.
METHODS: Autoimmune markers were analyzed in the sera of autistic and normal children, but the cerebrospinal fluid (CSF) of some autistic children was also analyzed. Laboratory procedures included enzyme-linked immunosorbent assay and protein immunoblotting assay.
RESULTS: Autoimmunity was demonstrated by the presence of brain autoantibodies, abnormal viral serology, brain and viral antibodies in CSF, a positive correlation between brain autoantibodies and viral serology, elevated levels of proinflammatory cytokines and acute-phase reactants, and a positive response to immunotherapy. Many autistic children harbored brain myelin basic protein autoantibodies and elevated levels of antibodies to measles virus and measles-mumps-rubella (MMR) vaccine. Measles might be etiologically linked to autism because measles and MMR antibodies (a viral marker) correlated positively to brain autoantibodies (an autoimmune marker)--salient features that characterize autoimmune pathology in autism. Autistic children also showed elevated levels of acute-phase reactants--a marker of systemic inflammation.
CONCLUSIONS: The scientific evidence is quite credible for our autoimmune hypothesis, leading to the identification of autoimmune autistic disorder (AAD) as a major subset of autism. AAD can be identified by immune tests to determine immune problems before administering immunotherapy. The author has advanced a speculative neuroautoimmune (NAI) model for autism, in which virus-induced autoimmunity is a key player. The latter should be targeted by immunotherapy to help children with autism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758536

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  25 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

Review 2.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 3.  Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance.

Authors:  Mohtashem Samsam; Raheleh Ahangari; Saleh A Naser
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Bridging the gap between MRI and postmortem research in autism.

Authors:  Cynthia Mills Schumann; Christine Wu Nordahl
Journal:  Brain Res       Date:  2010-09-22       Impact factor: 3.252

5.  Infections in children with autism spectrum disorder: Study to Explore Early Development (SEED).

Authors:  Katherine R Sabourin; Ann Reynolds; Diana Schendel; Steven Rosenberg; Lisa A Croen; Jennifer A Pinto-Martin; Laura A Schieve; Craig Newschaffer; Li-Ching Lee; Carolyn DiGuiseppi
Journal:  Autism Res       Date:  2018-11-26       Impact factor: 5.216

Review 6.  The Role of the Immune System in Autism Spectrum Disorder.

Authors:  Amory Meltzer; Judy Van de Water
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

7.  Above genetics: lessons from cerebral development in autism.

Authors:  Emily L Williams; Manuel F Casanova
Journal:  Transl Neurosci       Date:  2011-06-26       Impact factor: 1.757

8.  Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

Authors:  Richard E Frye; Swapna Sreenivasula; James B Adams
Journal:  BMC Pediatr       Date:  2011-05-18       Impact factor: 2.125

9.  Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia.

Authors:  Afaf K El-Ansary; Abir G Ben Bacha; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-10-15       Impact factor: 8.322

10.  Lipid mediators in plasma of autism spectrum disorders.

Authors:  Afaf El-Ansary; Laila Al-Ayadhi
Journal:  Lipids Health Dis       Date:  2012-11-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.